Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Reset all filters
01 3Strides Pharma Science
02 52care4
03 3ARCUTIS CANADA, INC.
04 1Abacus Medicine
05 1Abdi Ibrahim
06 2Accord healthcare
07 2Alkem Laboratories
08 3Arcutis Biotherapeutics
09 13AstraZeneca
10 2Aurobindo Pharma Limited
11 2Aurovitas Spain, Sau
12 2Ferrer Internacional
13 2Hetero Drugs
14 1KMS Health Center
15 1MS Pharma
16 2MSN Laboratories
17 1Medartuum
18 2Micro Labs Limited
19 3ORIFARM GROUP AS
20 1Orchid Pharma
21 1PHARMOBEDIENT
22 1Precise Group
23 1Prinston
24 2Senores Pharmaceuticals
25 1Takeda Pharmaceutical
26 4Torrent Pharmaceuticals Limited
27 2Zydus Pharmaceuticals
Reset all filters
01 4Antic-calc Tablet, Film Coated
02 2CREAM
03 2CREAM;TOPICAL
04 1FCT
05 1FOAM
06 1FOAM;TOPICAL
07 14Film Coated Tablet
08 1Roflumilast 500Mcg 30 Joined' Oral Use
09 3TABLET
10 22TABLET;ORAL
11 11Tablet
12 2Tablet, film-coated
Reset all filters
01 1Allowed
02 7Approved
03 5Authorized
04 3Cancelled
05 3DISCN
06 4Deregistered
07 2Generic
08 1Generic CTD, BE- Available
09 1Generic EU CTD
10 1Originator
11 4Prescription
12 22RX
13 10Blank
Reset all filters
01 1Charcoal
02 2DALIRESP
03 1DAXAS
04 1Daliresp
05 9Daxas
06 1Daxas 500 µg
07 1Daxas ug
08 1Libertek
09 2Quadruple
10 20ROFLUMILAST
11 1Roflumilast
12 2Roflumilast 2Care4
13 1Roflumilast Abdi
14 3Roflumilast Accord
15 2Roflumilast Aurovitas
16 2Roflumilast Ferrer
17 1Roflumilast Medartuum
18 1Roflumilast Orifarm
19 6ZORYVE
20 6Blank
Reset all filters
01 4Canada
02 6India
03 1Italy
04 1Jordan
05 6Norway
06 1South Africa
07 8Spain
08 11Sweden
09 1Switzerland
10 25USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2020-03-30
Application Number : 208247
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2023-06-20
Application Number : 208247
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name : Roflumilast
Dosage Form : Tablet
Dosage Strength : 500MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2023-04-18
Application Number : 212490
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DALIRESP
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2011-02-28
Application Number : 22522
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DALIRESP
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2018-01-23
Application Number : 22522
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2018-11-23
Application Number : 208213
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2023-04-18
Application Number : 208213
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2019-03-22
Application Number : 208180
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2023-04-18
Application Number : 208180
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2022-09-07
Application Number : 208256
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2022-09-07
Application Number : 208256
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2022-05-10
Application Number : 208299
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2018-10-03
Application Number : 208236
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2023-10-19
Application Number : 208236
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2018-08-06
Application Number : 208272
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2024-10-18
Application Number : 208272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2022-02-10
Application Number : 208303
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2023-04-18
Application Number : 208303
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2018-07-13
Application Number : 208257
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF